Loading company details...
Beta
Latest Form 4 (Sep 23, 2026): Carl L. Gordon (Director): Conversion of 2,002,310 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2026 | Carl L. Gordon | Conversion | 2,002,310 | n/a |
| Sep 23, 2026 | ORBIMED ADVISORS LLC | Conversion | 2,002,310 | n/a |
| Sep 21, 2026 | Gary S. Koe, Chief Technical Officer | Conversion | 63,656 | n/a |
| Sep 21, 2026 | Nancy Stagliano | Conversion | 255,635 | n/a |
| Sep 21, 2026 | Graham Parry, Chief Scientific Officer | Conversion | 85,504 | n/a |
| Sep 21, 2026 | Quehuong (Kathy) Dong, President & CEO | Conversion | 455,484 | n/a |